Logo

Venus Remedies Share Price

Venus Remedies (INR)296.6-4.8   (-1.6%)

Exchange ScripsBSE526953NSEVENUSREMISININE411B01019

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Venus Remedies Performance

Market performance
Open price304.75
High304.75
Volumes20464
Prev Close296.6
Low295
Closing date2025-01-10
Historical performance
1 Year High427.90
3 Year High430.00
5 Year High639.00
1 Year Low281.10
3 Year Low145.80
5 Year Low20.45

Venus Remedies Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
396
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
13.92
Dividend Yield
Dividend Yield
N/A

Venus Remedies Investment Returns

1 Year
-27.1%
3 Years
-27.2%
5 Years
1230%
10 Years
37.4%

Venus Remedies Technicals

IndicatorsValueSignal
5-DMA301.72Bearish
10-DMA309.12Bearish
20-DMA313.47Bearish
50-DMA313.12Bearish
100-DMA328.31Bearish
200-DMA337.78Bearish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters55555
Foreign Investors---------------
Domestic Investors55555
Public Investors1976619552196091990819555
Government---------------

Venus Remedies Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income11610383196
Operating Profit712703704734
Interest115130
Depreciation264323335353
Profit Before Tax446379364486
Consolidated Net Profit285266407618
Adjusted EPS21203050

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital134134134123
Total Reserves4742447042713742
Minority Interest------------
Total Non-Current Liabilities599582460581
Total Liabilities6268601157915559
Capital Work in Progress211261252251
Total Assets6268601157915559

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities3733664111318
Cash Flow from Investing Activities-72-508-167565
Cash Flow from Financing Activitie-11-6-95-1622
Net Cash Inflow / Outflow290-148149261
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 13.92.
  • 3Y Stock Price CAGR of the stock is -8.8.
  • The stock has a beta of 0.7.
  • In the last financial year, the company had an EBITDA of ₹712 Million.
  • The company generated revenue of ₹6014 Million in the previous financial year.

Venus Remedies

296.6-4.8   (-1.6%)

Investment Amount: ₹ 40820
Current Value: ₹ 29660
Performance: -27.3%
P/L: ₹ -11160
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month